Bank of New York Mellon’s MGC Diagnostics Corporation MGCD Stock Holding History

Bank of New York Mellon’s Portfolio MGCD Stock Details MGCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-10,290	Closed	-$67K	–	4342
2016 Q2	$67K	Hold	10,290	–	–	﹤0.01%	4130
2016 Q1	$63K	Hold	10,290	–	–	﹤0.01%	4051
2015 Q4	$68K	Hold	10,290	–	–	﹤0.01%	4136
2015 Q3	$68K	Hold	10,290	–	–	﹤0.01%	4204
2015 Q2	$59K	Sell	10,290 -648	-6%	-$4.03K	﹤0.01%	4148
2015 Q1	$79K	Hold	10,938	–	–	﹤0.01%	4091
2014 Q4	$70K	Hold	10,938	–	–	﹤0.01%	4116
2014 Q3	$72K	Hold	10,938	–	–	﹤0.01%	4123
2014 Q2	$91K	Hold	10,938	–	–	﹤0.01%	4007
2014 Q1	$125K	Hold	10,938	–	–	﹤0.01%	3948
2013 Q4	$138K	Hold	10,938	–	–	﹤0.01%	3945
2013 Q3	$120K	Hold	10,938	–	–	﹤0.01%	3913
2013 Q2	$91K	Buy	+10,938	New	+$79.6K	﹤0.01%	3947

Other funds holding MGCD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Bank of New York Mellon's MGCD Position: Q3 2016 in Review

Bank of New York Mellon sold out of MGC Diagnostics Corporation (MGCD) in Q3 2016, closing a stake of 10,290 shares — an estimated $67K sold.

Bank of New York Mellon first reported a position in MGCD in Q2 2013 and held it in 13 quarters. The position peaked at $138K in Q4 2013. 14 funds tracked by Wall St. Rank hold MGCD as of Q3 2016.

Bank of New York Mellon reported no remaining MGC Diagnostics Corporation position as of Q3 2016 after selling out during the quarter.
Bank of New York Mellon sold 10,290 MGC Diagnostics Corporation shares in Q3 2016, an estimated $67K.
Bank of New York Mellon first reported a position in MGC Diagnostics Corporation in Q2 2013 and held it in 13 quarters.
Bank of New York Mellon's MGC Diagnostics Corporation position peaked at $138K in Q4 2013.
14 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q3 2016.

Based on Bank of New York Mellon's 13F filing for Q3 2016, filed 3 Nov 2016.